SPIKEVAX

Google image searchProduct monograph

Active ingredient

*sarscov2 s-protein mrna, 5'(m7g-5'-ppp-5'-gm), 3'polya, 0.1 MG/ML

DIN: 02541270

Dosage form(s): DISPERSION

Route(s) of administration: INTRAMUSCULAR

Description: 2.5 ML MULTIDOSE VIAL

Schedule: Schedule D

Company: MODERNA BIOPHARMA CANADA CORPORATION

Date: 17-SEP-2024

ATC:

• J07 — VACCINES (ATC, ATC/DDD, )
• J07B — VIRAL VACCINES (ATC, ATC/DDD)
• J07BN — Covid-19 vaccines (ATC, ATC/DDD)
• J07BN01 — COVID-19, RNA-BASED VACCINE (ATC/DDD)

Reference brand drug: Comirnaty, Spikevax

External Links for Spikevax

Search on Google

• Spikevax side effects
• Spikevax dosage
• *sarscov2 s-protein mrna, 5'(m7g-5'-ppp-5'-gm), 3'polya side effects
• *sarscov2 s-protein mrna, 5'(m7g-5'-ppp-5'-gm), 3'polya dosage